학술논문
Adaptive Design Single Center Phosphodiesterase Type 4 (PDE4) Inhibitor - Ibudilast (MN-166-ALS-1201) Phase 1b/2a Clinical Trial Double-Blind (DB) with Open Label Extensions (OLE) [ NCT02238626 ] for Amyotrophic Lateral Sclerosis (ALS) Patients [1] Not Requiring Non-Invasive Ventilation (no-NIV) up to 5 Years (Early Cohort-EC) and [2] Requiring Non-Invasive Ventilation (NIV) up to 10 Years(Advanced NIV Cohort-ANC) from Disease Onset - Behavior of Creatinine as a Biomarker in Short Clinical Trials
Document Type
Journal
Author
Brooks, Benjamin; Bravver, Elena; Sanjak, Mohammed; Langford, Velma; Graves, Donna; Moore, Linda; Lary, Cynthia; Newell-Sturdivant, Allison; Russo, Priscilla; Burdette, Maryanne; Lucas, Nicole; Patterson, Charity; Anderson, William; Bockenek, William; Desai, Urvi; Lindblom, Scott; Dojillo, Joanna; Matsuda, Kazuko; Iwaki, Yuichi
Source
Subject
Language
English
ISSN
1526632X